MeiraGTx Quarterly Balance Sheet
NASDAQ: MGTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MeiraGTx financial position
As of Jun 30, 2026, MeiraGTx reported total assets of $396.4 million, up 99.5% from a year earlier against total liabilities of $180.7 million. Shareholders' equity stood at $215.8 million, or 54.4% of assets. The company held $143.2 million in cash and equivalents against $100.0 million of debt, a net cash position of $43.2 million.
The current ratio (current assets divided by current liabilities) was 3.76, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.46.
Summary generated from market data by MetaCap's automated system. Methodology
MeiraGTx balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 143.17M | 71.54M | 65.93M | 14.84M | 32.17M | 66.52M | 103.66M | 122.87M | 99.97M | 119.21M | 129.57M | 63.37M |
| Receivables | — | 3.26M | 3.00M | 2.81M | 2.32M | 734.00K | 707.00K | 3.28M | 1.63M | 10.91M | 10.14M | 22.40M |
| Inventory | — | — | — | — | 314.00K | 607.00K | 385.00K | — | — | — | — | — |
| Total Current Assets | 218.35M | 96.20M | 91.76M | 34.17M | 47.08M | 79.89M | 123.52M | 139.05M | 110.77M | 149.30M | 159.62M | 103.53M |
| Property, Plant & Equipment | 100.33M | 102.57M | 105.47M | 107.65M | 110.82M | 104.41M | 102.88M | 112.54M | 108.84M | 111.41M | 115.90M | 111.88M |
| Intangible Assets | 421.00K | 494.00K | 578.00K | 653.00K | 742.00K | 773.00K | 821.00K | 951.00K | 969.00K | 1.04M | 1.12M | 1.14M |
| Long-Term Investments | 39.84M | — | 6.75M | — | — | — | — | — | — | — | — | — |
| Total Assets | 396.45M | 244.66M | 244.43M | 189.47M | 198.72M | 224.01M | 269.75M | 299.49M | 266.65M | 309.24M | 326.74M | 267.19M |
| Accounts Payable | 11.67M | 16.66M | 10.07M | 21.54M | 25.59M | 20.29M | 23.59M | 29.50M | 21.40M | 21.22M | 16.04M | 20.77M |
| Total Current Liabilities | 58.10M | 176.13M | 122.56M | 152.92M | 53.44M | 52.37M | 60.78M | 59.42M | 47.01M | 47.54M | 67.08M | 63.51M |
| Long-Term Debt | 100.00M | 49.70M | 49.69M | — | 73.77M | 73.50M | 73.22M | 72.94M | 72.67M | 72.39M | 72.12M | 71.84M |
| Total Liabilities | 180.67M | 302.79M | 250.22M | 230.03M | 195.76M | 190.91M | 201.92M | 203.75M | 186.61M | 187.50M | 188.57M | 175.31M |
| Shareholders' Equity | 215.78M | -58.13M | -5.79M | -40.56M | 2.96M | 33.10M | 67.83M | 95.74M | 80.04M | 121.73M | 138.18M | 91.89M |
| Retained Earnings | -701.82M | -862.54M | -816.22M | -831.31M | -780.80M | -742.00M | -702.02M | -662.62M | -623.29M | -574.67M | -554.23M | -574.45M |
| Total Debt | 100.00M | 49.70M | 49.69M | — | 73.77M | 73.50M | 73.22M | 72.94M | 72.67M | 72.39M | 72.12M | 71.84M |
| Net Cash (Debt) | 43.17M | 21.84M | 16.24M | 14.84M | -41.61M | -6.97M | 30.44M | 49.93M | 27.31M | 46.81M | 57.45M | -8.48M |
| Shares Outstanding | 94.19M | 81.45M | 81.12M | 80.48M | 80.45M | 79.42M | 78.40M | 77.70M | 64.68M | 64.30M | 63.60M | 59.60M |
This table shows 12 quarterly periods of MeiraGTx's balance sheet, from Q2 2026 back to Q3 2023, across 17 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow MGTX's reporting calendar. What is a balance sheet?